Biopharmaceutical R&D Continues to Fight Covid-19

OPTUMRX

America’s biopharmaceutical companies continue to battle a once in a generation challenge by delivering safe and effective COVID-19 treatments and vaccines to American patients and other countries around the globe. As the world remains impacted by the COVID-19 pandemic, the biopharmaceutical industry is working around-the-clock to research, develop and manufacture treatments and vaccines to fight this virus.

Learn more about how our industry performs this vital work with the fact sheet below.

OPTUMRX